PuSH - Publikationsserver des Helmholtz Zentrums München: Highlights from the 2023 international meeting on the molecular biology of hepatitis B virus.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

HBV2023* ; Allweiss, L.* ; Cohen, C.* ; Dias, J.M.L.* ; Fumagalli, V.* ; Guo, H.* ; Harris, J.M.* ; Hu, J.* ; Iannacone, M.* ; Isogawa, M.* ; Jeng, W.J.* ; Kim, K.H.* ; Kramvis, A.* ; Li, W.* ; Lucifora, J.* ; Muramatsu, M.* ; Neuveut, C.* ; Ploss, A.* ; Pollicino, T.* ; Protzer, U. ; Tan, A.* ; Tanaka, Y.* ; Tu, T.* ; Tsukuda, S.* ; Thimme, R.* ; Urban, S.* ; Watashi, K.* ; Yuan, Z.* ; Yeh, S.H.* ; McKeating, J.A.* ; Revill, P.A.*

Highlights from the 2023 international meeting on the molecular biology of hepatitis B virus.

J. Gen. Virol. 105:001978 (2024)

Verlagsversion

DOI

PMC

	Open Access Hybrid

Abstract
Metriken
Zusatzinfos

Since its discovery in 1965, our understanding of the hepatitis B virus (HBV) replication cycle and host immune responses has increased markedly. In contrast, our knowledge of the molecular biology of hepatitis delta virus (HDV), which is associated with more severe liver disease, is less well understood. Despite the progress made, critical gaps remain in our knowledge of HBV and HDV replication and the mechanisms underlying viral persistence and evasion of host immunity. The International HBV Meeting is the leading annual scientific meeting for presenting the latest advances in HBV and HDV molecular virology, immunology, and epidemiology. In 2023, the annual scientific meeting was held in Kobe, Japan and this review summarises some of the advances presented at the Meeting and lists gaps in our knowledge that may facilitate the development of new therapies.

Impact Factor

Scopus SNIP

Altmetric

3.600

0.000